President Trump has signed an executive order on prescription drug prices that walks back the “pill penalty” decried by PhRMA in President Biden’s Inflation Reduction Act.
Category: Pharma, Finance, Financial management, Return on investment, Investing, Health and Wellness, Disease management, Life Sciences, Legislation, Regulation, Business, Care, Public Policy
